Pfizer Posts Higher Earnings on Drug Sales
692786
NEW YORK - Pfizer Inc. said Wednesday that third quarter earnings, excluding charges, beat Wall Street expectations by a penny, on strong sales of Lipitor and Celebrex medicines.
260262
Pfizer Inc, Novartis AG and Wyeth all saw quarterly earnings hit by charges on Thursday, while Eli Lilly and Co exceeded Wall Street expectations as third-quarter sales of several of its drugs outpaced analysts' estimates.
208276
Swiss drugs group Roche reports a 34% jump in annual profits, boosted by sales of its flu vaccine Tamiflu.
299345
Pfizer Inc. said Wednesday that third quarter earnings, excluding charges, beat Wall Street expectations by a penny, on strong sales of Lipitor and Celebrex medicines.
335265
Biogen Idec Inc.  said on Thursday that fourth-quarter earnings rose on higher sales of its cancer and multiple sclerosis drugs.
707960
German drugs and chemicals group Merck&#39;s third-quarter operating profit rose by a forecast-beating 42 percent, helped by strong sales of cancer drug Erbitux and liquid crystals for flat screen televisions.
733339
Eli Lilly and Co.  on Tuesday posted better-than-expected quarterly earnings and raised its 2007 forecast, helped by surging sales of its prescription drugs, including depression treatment Cymbalta.
736084
Biogen Idec Inc.  said on  Thursday that fourth-quarter earnings rose on higher sales of  its cancer and multiple sclerosis drugs.
477244
Pfizer Inc. PFE.N, the world's  biggest drugmaker, on Wednesday said third-quarter earnings  rose on higher sales of key medicines and favorable foreign  exchange factors.
197756
Helped by sales of generic drugs, the pharmacy benefit manager lifted its full-year profit forecast, sending its shares higher.
4273
The drugmaker said its third-quarter earnings more than doubled on a surge in sales of its blood thinner Plavix, and it raised its outlook for adjusted 2007 earnings.
299049
Eli Lilly and Co.  on Tuesday  posted better-than-expected second-quarter earnings helped by  surging sales of its prescription drugs, including depression  treatment Cymbalta, and the company raised its 2007 profit  forecast.
341429
Merck & Co.  on Monday said its  second-quarter earnings more than doubled on growing demand for  its drugs, blowing past Wall Street expectations, and raised  its full-year profit forecast.
360406
Abbott Laboratories Inc. ABT.N on  Tuesday said its fourth-quarter profit rose 3.2 percent, helped  by surging sales of two arthritis drugs, including one that  many doctors now deem safer than newer treatments such as  Pfizer Inc.'s Celebrex.
275333
Medco Health Solutions Inc. , one of the largest U.S. managers of drug benefits, said on Wednesday that profit rose 29 percent, as higher rates of mail-delivered generic drugs drove better profit margins, and it lifted its full-year earnings forecast.
135025
Walgreen Co., the top US drugstore chain, said Monday its quarterly profit rose 18.1 percent due to rising prescription demand and strong sales from its highly profitable nonpharmacy segment, including digital photo processing.
161514
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on higher-than-expected sales of its medicines, including strong demand for its newer treatments for depression, diabetes and cancer.